Skip to content

BBLG BONE BIOLOGICS CORP

Follow

COM (common), issuer CIK 1419554

Filings received so far for Q3 2026: 8 13F filers report a position in BBLG shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
ARMISTICE CAPITAL, LLCin group ARMISTICE CAPITAL, LLC290,000$144K<0.01%new13F-HRTimelineGroup
HRT FINANCIAL LP67,963$33K<0.01%new13F-HRTimeline
CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC42,126$20.9K<0.01%+18,24713F-HRTimelineGroup
Virtu Financial LLCin group Virtu Financial LLC20,694$10K<0.01%new13F-HRTimelineGroup
SUSQUEHANNA INTERNATIONAL GROUP, LLPin group SUSQUEHANNA INTERNATIONAL GRO…11,970$5.94K<0.01%new13F-HRTimelineGroup
Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T…2,244$1.11K<0.01%+29113F-HRTimelineGroup
SBI Securities Co., Ltd.341$169<0.01%+11113F-HRTimeline
Caitong International Asset Management …1$00%new13F-HRTimelineValue filed as zero, left out of ratios.

Events

  • ARMISTICE CAPITAL, LLC and 1 other reporting person reported 343,957 BBLG shares, 9.99% of the class, as of 2026-09-30, in a 13G filed 2026-11-16. 0001172661-26-005213

    Accepted , ingested
  • INTRACOASTAL CAPITAL, LLC and 2 other reporting persons reported 305,888 BBLG shares, 9.99% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-10. 0001213900-26-118156

    Accepted , ingested